Mirikizumab, sold under the brand name Omvoh, is a monoclonal antibody used for the treatment of ulcerative colitis. It is designed to attach to interleukin-
Mirikizumab, sold under the brand name Omvoh, is a monoclonal antibody used for the treatment of ulcerative colitis.
What is mirikizumab? Mirikizumab is a type of biologic medicine. It sticks to a protein called IL-23. Your immune system makes IL-23 to help you fight infections. But it can also cause inflammation. Mirikizumab blocks the effects of IL-23. This reduces gut inflammation. The brand name for mirikizumab is Omvoh. Who can have mirikizumab?
Brand Name. Azathioprine. Azasan, Imuran. Mercaptopurine. Purinethol. Page 5 Omvoh (mirikizumab-mrkz) [prescribing information]. Indianapolis, IN
Mirikizumab-mrkz (Omvoh) is an interleukin-23 antagonist. Therapeutic alternatives are listed as Brand name (generic) when the drug is
Generic Name. Brand Name. HCPCS Codes. Mirikizumab-mrkz. Omvoh. C9168. Additional Information. A complete list of office-administered Part B
Mirikizumab, which will be sold under the brand name Omvoh, joins a crowded inflammatory bowel disease market. Thursday's approval marks the
brand-name drugs in their healthcare programs. Laws in the U.S. Mirikizumab. Crohn's Disease. Phase III. Phase III trials are ongoing
mirikizumab. Lilly sees potential applications for the drug brand name Jaypirca. presented by. Health Tech The Promise of Value
Comments
Not my kink but well written!